Can I treat a sinus infection with a 5‑day course of Augmentin (amoxicillin‑clavulanate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Treat a Sinus Infection with 5 Days of Augmentin?

Yes, a 5-day course of Augmentin (amoxicillin-clavulanate) is an acceptable treatment duration for uncomplicated acute bacterial sinusitis in adults, though 10-14 days remains the traditional standard. The most recent 2025 guideline explicitly supports 5-7 day courses as equally effective with fewer side effects 1.

Treatment Duration: The Evidence

The 2025 AAO-HNS guideline update recommends 5-10 days of amoxicillin with or without clavulanate as first-line therapy 2, 1. This represents an evolution from older recommendations:

  • The 2005 guidelines suggested 10-14 days as standard 3
  • The 2015 guideline introduced flexibility with 5-10 day courses 2
  • The 2025 update explicitly states patients should be asked about 5-7 day courses since side effects are less common 1

Research supports this shorter duration. A 2000 multicenter study found 80% success with 5 days versus 85% with 10 days of amoxicillin-clavulanate—though statistical equivalence couldn't be definitively proven 4. A 2004 review concluded that evidence strongly supports reducing the traditional 10-day course to 5 days for uncomplicated acute maxillary sinusitis in adults 5.

Critical Caveats: When 5 Days Is NOT Enough

Do NOT use a 5-day course if the patient has:

  • Recurrent sinusitis (≥3 episodes per year)
  • Previous sinus surgery or drainage
  • Frontal, ethmoidal, or sphenoidal sinusitis (evidence only supports 5 days for maxillary sinusitis)
  • Immunocompromised state
  • Severe symptoms or complications (facial swelling, visual changes, neurologic signs)

These risk factors promote therapeutic failure with short courses 4. In these scenarios, use the full 10-14 day course.

The Watchful Waiting Alternative

Before prescribing any antibiotic, consider watchful waiting. The 2025 guideline extends this option to all patients with uncomplicated acute bacterial rhinosinusitis, regardless of severity 1. This is appropriate when:

  • Follow-up is assured within 7 days
  • No complications are present
  • Patient understands to start antibiotics if symptoms worsen or don't improve by day 7

This approach reduces antibiotic resistance and adverse events, as many patients improve spontaneously 2.

Amoxicillin vs. Augmentin: Which to Choose?

For first-line therapy, amoxicillin alone (without clavulanate) is now preferred unless the patient has failed initial amoxicillin therapy or lives in an area with high antibiotic resistance 2, 1.

The most recent 2026 research is compelling:

  • A large retrospective study of 234,608 adults found no difference in treatment failure between amoxicillin-clavulanate and amoxicillin alone (3.0% vs 3.1%) 6
  • However, amoxicillin-clavulanate caused significantly more yeast infections (1.1% vs 0.8%) and C. difficile infections (0.04% vs 0.02%) 6
  • Similar findings in pediatric patients: no efficacy difference but more GI symptoms and yeast infections with clavulanate 7

Reserve Augmentin (amoxicillin-clavulanate) for:

  • Patients who fail initial amoxicillin therapy after 3-5 days 3
  • Regions with high rates of beta-lactamase producing organisms
  • Patients with recent antibiotic use

Practical Treatment Algorithm

For uncomplicated acute bacterial sinusitis:

  1. First, confirm bacterial sinusitis (symptoms >10 days OR worsening after initial improvement OR severe symptoms with purulent discharge and facial pain for ≥3-4 consecutive days)

  2. Consider watchful waiting if follow-up assured—reassess at 7 days

  3. If prescribing antibiotics:

    • First-line: Amoxicillin 875 mg twice daily for 5-7 days (or up to 10 days)
    • If failed amoxicillin or high resistance area: Augmentin 875/125 mg twice daily for 5-7 days (or up to 10 days)
  4. Reassess at 3-5 days:

    • If improving: continue until well for 7 days (typically 10-14 days total) 3
    • If not improving: switch antibiotics (if on amoxicillin, switch to high-dose Augmentin; if on Augmentin, consider fluoroquinolone or cephalosporin) 3
  5. Extend to 10-14 days if:

    • Risk factors present (recurrent sinusitis, prior surgery)
    • Non-maxillary sinus involvement
    • Slow response to therapy

Common Pitfalls to Avoid

  • Don't prescribe antibiotics for viral rhinosinusitis (symptoms <10 days without worsening)
  • Don't use 5-day courses in high-risk patients (see exclusions above)
  • Don't forget adjunctive therapy: nasal saline irrigation, intranasal corticosteroids, and decongestants improve outcomes 3
  • Don't ignore treatment failure: If no improvement by day 7, reassess for complications, resistant organisms, or alternative diagnoses 2

The FDA label supports Augmentin use for acute bacterial sinusitis in both adults and children ≥3 months, with established safety profiles 8.

References

Guideline

executive summary of the clinical practice guideline on adult sinusitis update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Guideline

clinical practice guideline (update): adult sinusitis executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015

Guideline

the diagnosis and management of sinusitis: a practice parameter update.

Journal of Allergy and Clinical Immunology, 2005

Research

Short-course therapy for acute sinusitis: how long is enough?

Treatments in respiratory medicine, 2004

Related Questions

What is the appropriate dosage and duration of Augmentin (amoxicillin‑clavulanate) for treating acute bacterial sinusitis in an otherwise healthy adult?
What is the appropriate dose and duration of co-amoxiclav (amoxicillin/clavulanate) for acute sinusitis?
Can an adult who completed a 5‑ to 7‑day course of Augmentin (amoxicillin‑clavulanate) for sinusitis with nasal polyps and allergic rhinitis two weeks ago safely repeat the medication today?
What is the appropriate use and dosing of Augmentin (amoxicillin‑clavulanate) for acute bacterial sinusitis in adults and children?
A 35-year-old woman with sinus congestion and sore throat who completed a 7‑day course of Augmentin (amoxicillin‑clavulanate) reports worsening symptoms; what are the next steps in management?
After completing four cycles of platinum‑etoposide chemotherapy and thoracic radiation with a documented complete response in limited‑stage small cell lung cancer, what is the recommended next management, including surveillance and prophylactic cranial irradiation?
Do the 2023 guidelines (American Academy of Pediatrics, Italian Society of Neonatology, etc.) recommend serial clinical observation of newborns at risk for early‑onset sepsis to include vital sign measurements, and what frequency is advised during the first 24–48 hours and should these measurements be documented in the medical record?
Why is oxcarbazepine problematic?
In a hospice patient with diabetes mellitus who is taking insulin glargine (U100) 15 units subcutaneously at bedtime, should blood glucose be routinely checked?
What are the rules for responding only with verifiable sources, indicating whether the source was in effect as of November 2023, distinguishing guidelines, studies, and opinions, and stating "non lo so" if unsure?
What is the appropriate management of post‑traumatic stress disorder in an elderly patient, including psychotherapy, medication choices, dosing, and monitoring?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.